This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rasmussen, B. B. Articles by Wolfe, R. R. Search for Related Content PubMed PubMed Citation Articles by Rasmussen, B. B. Articles by Wolfe, R. R.

Androstenedione Does Not Stimulate Muscle Protein Anabolism in Young Healthy Men¹

Departments of Surgery (B.B.R., D.C.G., R.R.W.) and Internal Medicine (E.V.), University of Texas Medical Branch, and the Metabolism Department, Shriners Hospital (B.B.R., E.V., R.R.W.), Galveston, Texas 77550

Address all correspondence and requests for reprints to: Robert R. Wolfe, Ph.D., Shriners Hospital, Metabolism Department, 815 Market Street, Galveston, Texas 77550. E-mail: rwolfe{at}utmb.edu

Androstenedione is the immediate precursor of testosterone. Androstenedione intake has been speculated to increase plasma testosterone levels and muscle anabolism. Thus, androstenedione supplements have become widely popular in the sport community to improve performance. This study was designed to determine whether 5 days of oral androstenedione (100 mg/day) supplementation increases skeletal muscle anabolism.

Six healthy young men were studied before the treatment period and after 5 days of oral androstenedione supplementation. Muscle protein turnover parameters were compared to those of a control group studied twice as well and receiving no treatment. We measured muscle protein kinetics using a three-compartment model involving infusion of L-[ring-²H₅]phenylalanine, blood sampling from femoral artery and vein, and muscle biopsies. Plasma testosterone, androstenedione, LH, and estradiol concentrations were determined by RIA.

After ingestion of oral androstenedione, plasma testosterone and LH concentrations did not change from basal, whereas plasma androstenedione and estradiol concentrations were significantly increased (P < 0.05). Compared to a control group, androstenedione did not affect muscle protein synthesis and breakdown, or phenylalanine net balance across the leg.

We conclude that oral androstenedione does not increase plasma testosterone concentrations and has no anabolic effect on muscle protein metabolism in young eugonadal men.

This article has been cited by other articles:

				R. Jasuja, P. Ramaraj, R. P. Mac, A. B. Singh, T. W. Storer, J. Artaza, A. Miller, R. Singh, W. E. Taylor, M. L. Lee, et al. {Delta}-4-Androstene-3,17-Dione Binds Androgen Receptor, Promotes Myogenesis in Vitro, and Increases Serum Testosterone Levels, Fat-Free Mass, and Muscle Strength in Hypogonadal Men J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 855 - 863. [Abstract] [Full Text] [PDF]

				J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85. [Abstract] [Full Text] [PDF]

				T. Bassindale, D. A. Cowan, S. Dale, A. J. Hutt, A. R. Leeds, M. J. Wheeler, and A. T. Kicman Effects of Oral Administration of Androstenedione on Plasma Androgens in Young Women Using Hormonal Contraception J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6030 - 6038. [Abstract] [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, and D. S. King Urinary Excretion of Steroid Metabolites after Chronic Androstenedione Ingestion J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6235 - 6238. [Abstract] [Full Text] [PDF]

				J. M. Tokish, M. S. Kocher, and R. J. Hawkins Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports Am. J. Sports Med., September 1, 2004; 32(6): 1543 - 1553. [Abstract] [Full Text] [PDF]

				S G Beckham and C P Earnest Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men Br. J. Sports Med., June 1, 2003; 37(3): 212 - 218. [Abstract] [Full Text] [PDF]

				E. G. Boyce Use and Effectiveness of Performance-Enhancing Substances Journal of Pharmacy Practice, February 1, 2003; 16(1): 22 - 36. [Abstract] [PDF]

				A. T. Kicman, T. Bassindale, D. A. Cowan, S. Dale, A. J. Hutt, and A. R. Leeds Effect of Androstenedione Ingestion on Plasma Testosterone in Young Women; a Dietary Supplement with Potential Health Risks Clin. Chem., January 1, 2003; 49(1): 167 - 169. [Full Text] [PDF]

				B. Z. Leder, K. M. LeBlanc, C. Longcope, H. Lee, D. H. Catlin, and J. S. Finkelstein Effects of Oral Androstenedione Administration on Serum Testosterone and Estradiol Levels in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5449 - 5454. [Abstract] [Full Text] [PDF]

				G. A. Brown, E. R. Martini, B. S. Roberts, M. D. Vukovich, and D. S. King Acute hormonal response to sublingual androstenediol intake in young men J Appl Physiol, January 1, 2002; 92(1): 142 - 146. [Abstract] [Full Text] [PDF]

				M. I. Goran and B. A. Gower Longitudinal Study on Pubertal Insulin Resistance Diabetes, November 1, 2001; 50(11): 2444 - 2450. [Abstract] [Full Text] [PDF]

				B. Z. Leder, D. H. Catlin, C. Longcope, B. Ahrens, D. A. Schoenfeld, and J. S. Finkelstein Metabolism of Orally Administered Androstenedione in Young Men J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3654 - 3658. [Abstract] [Full Text] [PDF]

				C. E. Broeder, J. Quindry, K. Brittingham, L. Panton, J. Thomson, S. Appakondu, K. Breuel, R. Byrd, J. Douglas, C. Earnest, et al. The Andro Project: Physiological and Hormonal Influences of Androstenedione Supplementation in Men 35 to 65 Years Old Participating in a High-Intensity Resistance Training Program Arch Intern Med, November 13, 2000; 160(20): 3093 - 3104. [Abstract] [Full Text] [PDF]

				G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine Responses to Chronic Androstenedione Intake in 30- to 56-Year-Old Men J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4074 - 4080. [Abstract] [Full Text]

				R. Palusinski, W. Barud, T. O'Gara, K. Ullis, T. N. Ziegenfuss, R. Cohen, W. D. Brink, W. J. Roberts, D. S. King, R. L. Sharp, et al. Effects of Androstenedione in Young Men JAMA, February 9, 2000; 283(6): 741 - 743. [Full Text] [PDF]